Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Lung Neoplasms and meta-analysis and VEGF[original query] |
|---|
| Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 859-70. Song Ning, Liu Bao, Wu Jianling, Zhang Rufang, Duan Lin, He Wenshu, Zhang Congm |
| Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis. PloS one 2013 8 (10): e75123. Lin Ling, Cao Kejian, Chen Wenhu, Pan Xufeng, Zhao He |
| Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Mar 35 (3): 1805-11. Deng Zai-Chun, Cao Chao, Yu Yi-Ming, Ma Hong-Ying, Ye Me |
| rs833061 and rs699947 on promoter gene of vascular endothelial growth factor (VEGF) and associated lung cancer susceptibility and survival: a meta-analysis. Medical science monitor : international medical journal of experimental and clinical research 2014 20 2520-6. Tu Junwei, Wang Saibin, Zhao Jianping, Zhu Jingqian, Sheng Lin, Sheng Yijun, Chen Huijun, Tian Jiangh |
| Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update. Biomedical reports 2014 Nov 2 (6): 823-830. Chen Quanchi, Zhou Zifei, Shan Liangcheng, Hua Yingqi, Zeng Hui, Liu Pengcheng, Cai Zhengdo |
| Vascular endothelial growth factor polymorphisms and lung cancer risk. International journal of clinical and experimental medicine 2015 8 (4): 6406-11. Fan Junli, Zhang Weiguo, Lei Caipeng, Qiao Bin, Liu Qin, Chen Qiang, Jiao Hongduo, Jiang Leizhen, Cui Shuo, Chen Jianm |
| Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis. BioMed research international 2018 2018 9271215. Yang Fengming, Qin Zhiqiang, Shao Chuchu, Liu Weitao, Ma Ling, Shu Yongqian, Shen H |
| Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Current oncology reports 2020 Sep 22 (12): 119. Peravali Monica, Wang Haijun, Kim Chul, Veytsman Iri |
| First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation. Journal of cancer research and clinical oncology 2020 Jul . Landre Thierry, Des Guetz Gaetan, Chouahnia Kader, Duchemann Boris, Assié Jean-Baptiste, Chouaid Christ |
| Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis. Medicine 2020 Jan 99 (3): e18771. Zhou Kenan, Zhao Shishun, Guo Wenlai, Ding L |
| Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis. BMC medical genetics 2020 Jan 21 (1): 17. Zhao Hui-Liu, Yu Jia-Hua, Huang Ling-Sha, Li Pei-Zhang, Lao Ming, Zhu Bo, Ou Ch |
| Chemotherapy and programmed cell death protein 1/programmed death-ligand 1 inhibitor combinations for tyrosine kinase inhibitor-resistant, epidermal growth factor receptor-mutated non-small-cell lung cancer: a meta-analysis. ESMO open 2024 8 9 (9): 103660. Z Piotrowska, B Y Yeap, J F Gain |
- Page last reviewed:Feb 1, 2024
- Content source: